Literature DB >> 25959397

LOXL2 Oxidizes Methylated TAF10 and Controls TFIID-Dependent Genes during Neural Progenitor Differentiation.

Ane Iturbide1, Laura Pascual-Reguant1, Laura Fargas2, Joan Pau Cebrià1, Berta Alsina2, Antonio García de Herreros3, Sandra Peiró4.   

Abstract

Protein function is often regulated and controlled by posttranslational modifications, such as oxidation. Although oxidation has been mainly considered to be uncontrolled and nonenzymatic, many enzymatic oxidations occur on enzyme-selected lysine residues; for instance, LOXL2 oxidizes lysines by converting the ε-amino groups into aldehyde groups. Using an unbiased proteomic approach, we have identified methylated TAF10, a member of the TFIID complex, as a LOXL2 substrate. LOXL2 oxidation of TAF10 induces its release from its promoters, leading to a block in TFIID-dependent gene transcription. In embryonic stem cells, this results in the inactivation of the pluripotency genes and loss of the pluripotent capacity. During zebrafish development, the absence of LOXL2 resulted in the aberrant overexpression of the neural progenitor gene Sox2 and impaired neural differentiation. Thus, lysine oxidation of the transcription factor TAF10 is a controlled protein modification and demonstrates a role for protein oxidation in regulating pluripotency genes.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25959397     DOI: 10.1016/j.molcel.2015.04.012

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  12 in total

1.  LOXL2-mediated H3K4 oxidation reduces chromatin accessibility in triple-negative breast cancer cells.

Authors:  J P Cebrià-Costa; L Pascual-Reguant; A Gonzalez-Perez; G Serra-Bardenys; J Querol; M Cosín; G Verde; R A Cigliano; W Sanseverino; S Segura-Bayona; A Iturbide; D Andreu; P Nuciforo; C Bernado-Morales; V Rodilla; J Arribas; J Yelamos; A Garcia de Herreros; T H Stracker; S Peiró
Journal:  Oncogene       Date:  2019-08-28       Impact factor: 9.867

Review 2.  Epigenetic control of transcriptional regulation in pluripotency and early differentiation.

Authors:  Deniz Gökbuget; Robert Blelloch
Journal:  Development       Date:  2019-09-25       Impact factor: 6.868

Review 3.  Lysyl Oxidase Isoforms and Potential Therapeutic Opportunities for Fibrosis and Cancer.

Authors:  Philip C Trackman
Journal:  Expert Opin Ther Targets       Date:  2016-03-03       Impact factor: 6.902

4.  Genetic Pathways of Neuroregeneration in a Novel Mild Traumatic Brain Injury Model in Adult Zebrafish.

Authors:  Amanda L Maheras; Brian Dix; Olivia M S Carmo; Aleena E Young; Vanessa N Gill; Julia L Sun; Aleah R Booker; Helen A Thomason; Anastasia E Ibrahim; Lauren Stanislaw; Jennifer C Dallego; Cat N Ngo; Audrey Chen; Barbara K Fortini; Rory D Spence
Journal:  eNeuro       Date:  2018-01-03

5.  LOXL2 as a protective in osteoarthritis cartilage.

Authors:  Manish V Bais; Mary B Goldring
Journal:  Aging (Albany NY)       Date:  2017-10-27       Impact factor: 5.682

6.  Mechanism for oral tumor cell lysyl oxidase like-2 in cancer development: synergy with PDGF-AB.

Authors:  Faranak Mahjour; Vrinda Dambal; Neha Shrestha; Varun Singh; Vikki Noonan; Alpdogan Kantarci; Philip C Trackman
Journal:  Oncogenesis       Date:  2019-05-13       Impact factor: 7.485

7.  Discovery and evaluation of inhibitor of LARP6 as specific antifibrotic compound.

Authors:  Branko Stefanovic; Zarko Manojlovic; Cynthia Vied; Crystal-Dawn Badger; Lela Stefanovic
Journal:  Sci Rep       Date:  2019-01-23       Impact factor: 4.379

8.  Anabolic role of lysyl oxidase like-2 in cartilage of knee and temporomandibular joints with osteoarthritis.

Authors:  Weam Alshenibr; Mustafa M Tashkandi; Saqer F Alsaqer; Yazeed Alkheriji; Amelia Wise; Sadanand Fulzele; Pushkar Mehra; Mary B Goldring; Louis C Gerstenfeld; Manish V Bais
Journal:  Arthritis Res Ther       Date:  2017-08-02       Impact factor: 5.156

9.  Dormant tumor cells expressing LOXL2 acquire a stem-like phenotype mediating their transition to proliferative growth.

Authors:  Keren Weidenfeld; Sagi Schif-Zuck; Hanan Abu-Tayeh; Keunsoo Kang; Ofra Kessler; Marina Weissmann; Gera Neufeld; Dalit Barkan
Journal:  Oncotarget       Date:  2016-11-01

10.  Lysyl oxidase-like 2 is a regulator of angiogenesis through modulation of endothelial-to-mesenchymal transition.

Authors:  Olivier G de Jong; Lizet M van der Waals; Farah R W Kools; Marianne C Verhaar; Bas W M van Balkom
Journal:  J Cell Physiol       Date:  2018-11-01       Impact factor: 6.384

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.